Siim Land: What People Get Wrong About the Rapamycin Trial

🟢
Peer-Reviewed Research
S
Siim Land

Video Summary · May 3, 2026

View Full Protocol →

Key Takeaways

  • Rapamycin may hinder exercise gains, especially in the elderly, but it does not completely block benefits.
  • If using Rapamycin, consider adjusting dosage or timing to avoid blunting exercise results.
  • Rapamycin’s potential longevity benefits remain unproven; it may still promote lifespan despite reduced exercise gains.

Notable Quotes

“Rapamycin didn’t completely block the benefits of exercise. They just saw slightly worse results.”

Bottom Line

If you’re taking Rapamycin, optimize timing and dosage to minimize interference with exercise gains, especially if you’re older.

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts